CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Clinical trial NCT02942173 · COMPLETED

Trial details

NCT number: NCT02942173
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Leukemia Lymphoma Myelodysplastic Syndromes GvHD Opportunistic Infections Graft-versus-Host Disease

Start date: 2016-10-01
Primary completion: 2019-08-21
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.